![Daniel Bendheim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Bendheim
Directeur Général chez
PHIBRO ANIMAL HEALTH CORPORATION
Fortune : 551 380 $ au 31/07/2026
Profil
Daniel M.
Bendheim is currently President, Chief Executive Officer & Director at Phibro Animal Health Corp.
since 2026.
Mr. Bendheim is also Manager at BFI Co. LLC.
Education history includes an undergraduate degree from Yeshiva University conferred in 1993 and a graduate degree from Harvard Law School conferred in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/08/2026 | 15 177 ( 0,07 % ) | 551 380 $ | 31/07/2026 |
Postes actifs de Daniel Bendheim
| Sociétés | Poste | Début |
|---|---|---|
| PHIBRO ANIMAL HEALTH CORPORATION | Directeur Général | 01/07/2026 |
BFI Co. LLC
 BFI Co. LLC Financial ConglomeratesFinance Operates as an investment vehicle | Corporate Officer/Principal | - |
Formation de Daniel Bendheim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Phibro Animal Health Corp.
 Phibro Animal Health Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets animal health pharmaceutical and nutritional products | Health Technology |
Yeshiva University
 Yeshiva University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BFI Co. LLC
BFI Co. LLC Financial ConglomeratesFinance Operates as an investment vehicle | Finance |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
